USD 0.02
(3.88%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 580.16 Thousand USD | -7.07% |
2022 | 624.27 Thousand USD | -0.2% |
2021 | 625.51 Thousand USD | 4.82% |
2020 | 596.74 Thousand USD | 1.99% |
2019 | 585.11 Thousand USD | 3.74% |
2018 | 564 Thousand USD | -20.85% |
2017 | 712.57 Thousand USD | 0.0% |
2015 | 429.89 Thousand USD | -68.17% |
2014 | 1.35 Million USD | 91429.45% |
2013 | 1475.45 USD | 0.0% |
2009 | 179.35 Thousand USD | -36.73% |
2008 | 283.48 Thousand USD | -25.74% |
2007 | 381.73 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 579.54 Thousand USD | -0.05% |
2024 Q1 | 579.85 Thousand USD | -0.05% |
2023 Q4 | 580.16 Thousand USD | -0.05% |
2023 Q2 | 623.65 Thousand USD | -0.05% |
2023 Q1 | 623.96 Thousand USD | -0.05% |
2023 FY | 580.16 Thousand USD | -7.07% |
2023 Q3 | 580.47 Thousand USD | -6.92% |
2022 Q1 | 625.2 Thousand USD | -0.05% |
2022 Q2 | 624.89 Thousand USD | -0.05% |
2022 Q3 | 624.58 Thousand USD | -0.05% |
2022 FY | 624.27 Thousand USD | -0.2% |
2022 Q4 | 624.27 Thousand USD | -0.05% |
2021 Q3 | 625.81 Thousand USD | -0.05% |
2021 FY | 625.51 Thousand USD | 4.82% |
2021 Q2 | 626.13 Thousand USD | -0.05% |
2021 Q1 | 626.43 Thousand USD | 0.0% |
2021 Q4 | 625.51 Thousand USD | -0.05% |
2020 FY | 596.74 Thousand USD | 1.99% |
2019 FY | 585.11 Thousand USD | 3.74% |
2018 FY | 564 Thousand USD | -20.85% |
2017 FY | 712.57 Thousand USD | 0.0% |
2015 FY | 429.89 Thousand USD | -68.17% |
2014 Q4 | 1350.48 USD | -2.37% |
2014 Q2 | 1416.90 USD | -2.34% |
2014 FY | 1.35 Million USD | 91429.45% |
2014 Q1 | 1450.77 USD | -1.67% |
2014 Q3 | 1383.28 USD | -2.37% |
2013 Q4 | 1475.45 USD | -18.13% |
2013 FY | 1475.45 USD | 0.0% |
2013 Q3 | 1802.22 USD | 0.04% |
2013 Q1 | 1815.77 USD | 0.0% |
2013 Q2 | 1801.50 USD | -0.79% |
2010 Q2 | 141.63 Thousand USD | -12.85% |
2010 Q1 | 162.51 Thousand USD | -9.39% |
2010 Q3 | 121.26 Thousand USD | -14.38% |
2009 Q2 | 274.39 Thousand USD | 0.13% |
2009 Q1 | 274.04 Thousand USD | 0.0% |
2009 FY | 179.35 Thousand USD | -36.73% |
2009 Q4 | 179.35 Thousand USD | -33.23% |
2009 Q3 | 268.61 Thousand USD | -2.11% |
2008 FY | 283.48 Thousand USD | -25.74% |
2007 FY | 381.73 Thousand USD | 0.0% |
2007 Q1 | 501.42 Thousand USD | 0.0% |
2007 Q2 | 484.97 Thousand USD | -3.28% |
Name | Total Assets | Total Assets Difference |
---|---|---|
China Medicine Corporation | 66.84 Million USD | 99.132% |
DH Enchantment Inc. | 3814.00 USD | -15111.379% |
Exlites Holdings International, Inc. | 445.71 Thousand USD | -30.165% |
Itonis, Inc. | 92.35 Thousand USD | -528.2% |
MediPal Holdings Corporation | 11.88 Billion USD | 99.995% |
PD-Rx Pharmaceuticals, Inc. | 12.95 Million USD | 95.52% |
Pharmagen, Inc. | 1282.30 USD | -45143.859% |
Suzuken Co., Ltd. | 8.11 Billion USD | 99.993% |